tiprankstipranks
Candel Therapeutics (CADL)
NASDAQ:CADL
US Market

Candel Therapeutics (CADL) Financial Statements

168 Followers

Candel Therapeutics Financial Overview

Candel Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.288; its P/E ratio is -4.89; Candel Therapeutics is scheduled to report earnings on September 4, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue----$ 7.00K
Gross Profit----$ 7.00K
EBIT$ -7.58M$ -7.77M$ -8.97M$ -8.90M$ -5.33M
EBITDA$ -7.32M$ -7.52M-$ -9.10M$ -5.58M
Net Income Common Stockholders$ -8.22M$ -8.44M$ -9.61M$ -8.79M$ -5.11M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 25.71M$ 42.98M$ 51.89M$ 59.26M$ 70.06M
Total Assets$ 31.22M$ 50.06M$ 58.71M$ 67.24M$ 77.69M
Total Debt$ 21.09M$ 22.77M$ 22.78M$ 22.79M$ 22.80M
Net Debt$ -4.63M$ -20.21M$ -29.11M$ -36.47M$ -47.26M
Total Liabilities$ 25.24M$ 27.04M$ 27.94M$ 27.59M$ 29.98M
Stockholders Equity$ 5.98M$ 23.02M$ 30.77M$ 39.65M$ 47.71M
Cash Flow-
Free Cash Flow$ -8.45M$ -8.91M-$ -10.80M$ -7.16M
Operating Cash Flow$ -8.44M$ -8.81M-$ -10.82M$ -6.88M
Investing Cash Flow$ -7.00K$ -103.00K-$ 19.00K$ -276.00K
Financing Cash Flow$ -1.25M---$ 36.00K
Currency in USD

Candel Therapeutics Earnings and Revenue History

Candel Therapeutics Debt to Assets

Candel Therapeutics Cash Flow

Candel Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis